ATLANTA, Oct. 10, 2017 -- Matrix Surgical USA introduced patented (#US0D0794794) innovations designed to address two of the etiologies that most frequently cause cranial implant exposure at the CNS 2017 Annual Meeting. While computer designed and manufactured implants allow precise anatomic reconstruction of skull defects, they can be plagued by complications requiring implant removal.
“Cranial implant exposure is not uncommon and results in significant, avoidable patient morbidity and expense,” said Dr. Michael J. Yaremchuk, Chief of Craniofacial Surgery, Massachusetts General Hospital. Dr. Yaremchuk designed the cranioplasty innovations which are exclusively licensed to Matrix Surgical.
Affixing Cranial Implants
The plates and screws that typically affix cranial implants to the adjacent intact cranium almost inevitably have a profile above the surface of the implant/skull interface. Matrix Surgical’s new, patented lag screw design not only eliminates the problem of prominent fixation hardware, it also streamlines and simplifies the fixation process.
During the computer design process, the surgeon has the ability to select where the oblique holes are placed in the implant that allows fixation screws to remain within the surface contour of the implant.
Integrating Subcranial Drains
Decreases in brain volume following trauma or neurosurgery can lead to the creation of a space between the surface of the brain and the cranial implant. Fluid inevitably collects in this space and is susceptible to contamination and infection.
With Matrix Surgical’s patented design, a drain hole is strategically positioned in the implant to allow passage of a removable drain between the cranial cavity and the inner surface of the skull. The drain port’s dimensions can be customized to fit the surgeon’s preferred drain.
About Matrix Surgical USA
Matrix Surgical USA is a privately owned American company dedicated to the design, production, marketing and distribution of sterile, biocompatible craniofacial implants. Matrix Surgical USA offers its products to healthcare providers in the United States and in more than 60 countries around the world. Learn more at www.MatrixSurgicalUSA.com.
Media Contact: Lynn Hood, [email protected], 678-974-2623


Chinese Cars in Europe: Consumer Trust Is Shifting Fast
Chalco Stock Surges as Q1 2025 Profit Forecast Jumps Up to 58%
Rio Tinto's California Boron Assets Attract Over a Dozen Bidders, Valued at Up to $2 Billion
Anthropic's Mythos AI Model Sparks Emergency Cybersecurity Meeting With Top U.S. Bank CEOs
Anthropic Fights Pentagon Blacklisting in Dual Federal Court Battles
MATCH Act: How New U.S. Chip Legislation Could Freeze China's Semiconductor Ambitions
TSMC Posts Strong Q1 2025 Revenue, Riding AI Chip Demand Wave
Abbott Laboratories Ordered to Pay $53 Million in Premature Infant Formula Lawsuit
Bill Ackman Eyes New Fund to Bet Against Market Complacency
Tokyo Electric Power Attracts Major Investors Amid Billion-Dollar Restructuring Push
Chinese Brands Are Taking Over Brazil — And It's Just Getting Started
Pony.ai, Uber, and Verne Launch Europe's First Commercial Robotaxi Service in Zagreb
SanDisk Joins Nasdaq-100, Replacing Atlassian on April 20
BHP's Incoming CEO Visits China Amid Pricing Dispute with CMRG
NIO ES9 SUV Launch Sends HK Shares Down 7% Despite Bold Pricing Strategy
Foreign Investors Pour $18.65 Billion into Japanese Stocks Amid Market Stabilization
Bendigo and Adelaide Bank Posts Strong Q3 Earnings, Announces AI-Driven Job Cuts 



